Oral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case–control study

BACKGROUND: Data on the effect of oral bisphosphonates (BPs) on risk of upper gastrointestinal complications (UGIC) are conflicting. We conducted a large population-based study from a network of Italian healthcare utilization databases aimed to assess the UGIC risk associated with use of BPs in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghirardi, Arianna, Scotti, Lorenza, Vedova, Gianluca Della, D’Oro, Luca Cavalieri, Lapi, Francesco, Cipriani, Francesco, Caputi, Achille P, Vaccheri, Alberto, Gregori, Dario, Gesuita, Rosaria, Vestri, Annarita, Staniscia, Tommaso, Mazzaglia, Giampiero, Corrao, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897893/
https://www.ncbi.nlm.nih.gov/pubmed/24397769
http://dx.doi.org/10.1186/1471-230X-14-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897893/
https://www.ncbi.nlm.nih.gov/pubmed/24397769
http://dx.doi.org/10.1186/1471-230X-14-5

Ejemplares similares